Gene therapy for rheumatoid arthritis: current status and future prospects.
about
Immunomodulation of cystic fibrosis epithelial cells via NF-κB decoy oligonucleotide-coated polysaccharide nanoparticles.Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.Therapeutic effect of emodin on collagen-induced arthritis in mice.
P2860
Gene therapy for rheumatoid arthritis: current status and future prospects.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gene therapy for rheumatoid arthritis: current status and future prospects.
@en
Gene therapy for rheumatoid arthritis: current status and future prospects.
@nl
type
label
Gene therapy for rheumatoid arthritis: current status and future prospects.
@en
Gene therapy for rheumatoid arthritis: current status and future prospects.
@nl
prefLabel
Gene therapy for rheumatoid arthritis: current status and future prospects.
@en
Gene therapy for rheumatoid arthritis: current status and future prospects.
@nl
P2860
P1433
P1476
Gene therapy for rheumatoid arthritis: current status and future prospects.
@en
P2093
Florence Apparailly
Sylvie Fabre
P2860
P304
P356
10.2165/11595490-000000000-00000
P577
2011-12-01T00:00:00Z
P6179
1038519213